Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Apo- and Holo-Lactoferrin Are Both Internalized by Lactoferrin Receptor via Clathrin-Mediated Endocytosis But Differentially Affect ERK-Signaling and Cell Proliferation in Caco-2 Cells
Apo-metallothionein emerging as a major player in the cellular activities of metallothionein
Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism
Apo-intermediate in the transport cycle of lactose permease (LacY)
Apo-RBP, Holo-RBP, and Insulin Resistance
Apo-10 '-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors
Apo- and Cellopentaose-bound Structures of the Bacterial Cellulose Synthase Subunit BcsZ
Apo-10 '-lycopenoic acid inhibits cancer cell migration and angiogenesis and induces peroxisome proliferator-activated receptor gamma
Apo-1/Fas和Apo-1/Fas配体在中枢神经系统疾病中的作用
Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma
Apo2.7抗体标记原位法在SLE患者外周血淋巴细胞凋亡检测中的应用
Apo2.7抗体标记法原位检测细胞凋亡
Apo2.7抗体原位标记法在原发性肝癌病人外周血淋巴细胞凋亡检测中的应用价值
ApoA1基因多态性与乳腺癌发病相关性的研究
ApoA-I半胱氨酸突变体rHDL对大鼠急性痛风性关节炎影响
ApoA5和HDL与心血管疾病关系的研究进展
ApoAⅠ/ABCA1通过STAT3/TTP途径调节炎症因子mRNA降解
ApoA5基因单核苷酸多态性与代谢综合征的相关性
ApoA_1、ApoB及其基因多态性与NONFH体质类型的相关性
ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT
ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C
ApoA-I mimetics: tomatoes to the rescue
ApoA-I保护小鼠内毒素性急性肝损伤
ApoAI、B基因多态性与非创伤性股骨头坏死证候相关性研究
apoA-I,apoB和LP(a)与冠状动脉病变程度的相关性分析
ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy
ApoAI/ABCA1途径对糖尿病肾病大鼠的保护作用
ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety
ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation
ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta
ApoA-1 in Diabetes: Damaged Goods
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease
ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans
ApoA-I mimetic peptides promote pre-beta HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose
ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis
ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: Implications for vascular repair
ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signaling
ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression
ApoA-I-Directed Therapies for the Management of Atherosclerosis
ApoAI-CⅢ-AIV基因簇多态性对痛风伴胰岛素抵抗患者高脂血症的作用
ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance
ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase C gamma in rat astrocytes
ApoA1 Mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b
ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling
ApoA-1 Mimetic Peptide ELK-2A2K2E Decreases Inflammatory Factor Levels Through the ABCA1-JAK2-STAT3-TTP Axis in THP-1-Derived Macrophages
ApoB-INDEPENDENT ENZYME IMMUNOASSAY FOR LIPOPROTEIN(a) BY CAPTURE ON IMMOBILIZED LECTIN (JACALIN)
apoB/apoA1与冠状动脉病变的相关性分析
ApoB基因多态性与HCV感染易感性关系
ApoB和ApoB/ApoA-Ⅰ比值在冠心病危险性预测中的应用
ApoB100/ApoA1比值对老年冠心病患者经皮冠状动脉介入治疗后的预测作用
ApoB RNA编辑高效蛋白检测体系的构建
apoB/apoA1值与冠心病相关性研究进展
ApoB gene SpIns/Del, XbaI polymorphisms and myocardial infarction: a meta-analysis of 7169 participants
ApoB/ApoA-I Ratio Is Associated With Increased Risk of Bioprosthetic Valve Degeneration
ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
ApoB与UCP基因间上位效应对鸡腹脂性状影响的遗传学分析
ApoB、ApoE基因多态性与血脂异常的关系及运动训练的影响
ApoBR在布鲁氏菌侵染过程中对细胞凋亡影响的研究
ApoB、ApoB/ApoA Ⅰ值与冠状动脉病变的关系研究进展
ApoB100基因第26号外显子6694bp处MspⅠ位点突变与高血脂相关性
ApoB基因对鸡脂肪代谢的调控以及日粮对其表达的影响
ApoB基因多态性与新疆维吾尔族胆结石的相关性研究
ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease
apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53
ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1
ApoB-100-Related Peptide Vaccine Protects Against Angiotensin II-Induced Aortic Aneurysm Formation and Rupture
ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans
ApoB基因rs676210和rs2854725位点多态性与胆囊结石的相关性研究
ApoB基因XbaI-RFLP与生活方式在浙江汉族人长寿发生中的交互作用
ApoB and apoM - New aspects of lipoprotein biology in uremia-induced
ApoB siRNA-induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5)
ApoB-100-containing Lipoproteins Are Major Carriers of 3-Iodothyronamine in Circulation
ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study
ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels